Global At-Home Drug of Abuse (DOA) Testing Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI12245639

Publication Date:

December 23, 2024

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global At-Home Drug of Abuse (DOA) Testing market size was valued at US$ 404.2 million in 2023. With growing demand in downstream market, the At-Home Drug of Abuse (DOA) Testing is forecast to a readjusted size of US$ 839 million by 2030 with a CAGR of 11.0% during review period.
The research report highlights the growth potential of the global At-Home Drug of Abuse (DOA) Testing market. At-Home Drug of Abuse (DOA) Testing are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of At-Home Drug of Abuse (DOA) Testing. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the At-Home Drug of Abuse (DOA) Testing market.
The at-home DOA testing market has been categorized into rapid DOA test kits and breath analyzers.
The market is mainly driven by the increased production and trade of illicit drugs worldwide, growing use of illicit drugs amongst teenagers, and initiatives by government organizations to reduce the level of drug abuse.
Key Features:
The report on At-Home Drug of Abuse (DOA) Testing market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the At-Home Drug of Abuse (DOA) Testing market. It may include historical data, market segmentation by Type (e.g., Test Cups, Test Dip Cards), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the At-Home Drug of Abuse (DOA) Testing market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the At-Home Drug of Abuse (DOA) Testing market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the At-Home Drug of Abuse (DOA) Testing industry. This include advancements in At-Home Drug of Abuse (DOA) Testing technology, At-Home Drug of Abuse (DOA) Testing new entrants, At-Home Drug of Abuse (DOA) Testing new investment, and other innovations that are shaping the future of At-Home Drug of Abuse (DOA) Testing.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the At-Home Drug of Abuse (DOA) Testing market. It includes factors influencing customer ' purchasing decisions, preferences for At-Home Drug of Abuse (DOA) Testing product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the At-Home Drug of Abuse (DOA) Testing market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting At-Home Drug of Abuse (DOA) Testing market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the At-Home Drug of Abuse (DOA) Testing market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the At-Home Drug of Abuse (DOA) Testing industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the At-Home Drug of Abuse (DOA) Testing market.
Market Segmentation:
At-Home Drug of Abuse (DOA) Testing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Test Cups
Test Dip Cards
Test Strips
Others
Segmentation by application
Urine
Saliva
Hair
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
UCP Biosciences
Orient New Life Medical
Express Diagnostics Int鈥檒
Assure Tech (Hangzhou)
Psychemedics Corporation
Confirm BioSciences
Phamatech
Home Health (U.K.) Ltd.
Quest Products

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global At-Home Drug of Abuse (DOA) Testing Market Size 2019-2030
2.1.2 At-Home Drug of Abuse (DOA) Testing Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 At-Home Drug of Abuse (DOA) Testing Segment by Type
2.2.1 Test Cups
2.2.2 Test Dip Cards
2.2.3 Test Strips
2.2.4 Others
2.3 At-Home Drug of Abuse (DOA) Testing Market Size by Type
2.3.1 At-Home Drug of Abuse (DOA) Testing Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global At-Home Drug of Abuse (DOA) Testing Market Size Market Share by Type (2019-2024)
2.4 At-Home Drug of Abuse (DOA) Testing Segment by Application
2.4.1 Urine
2.4.2 Saliva
2.4.3 Hair
2.4.4 Others
2.5 At-Home Drug of Abuse (DOA) Testing Market Size by Application
2.5.1 At-Home Drug of Abuse (DOA) Testing Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global At-Home Drug of Abuse (DOA) Testing Market Size Market Share by Application (2019-2024)
3 At-Home Drug of Abuse (DOA) Testing Market Size by Player
3.1 At-Home Drug of Abuse (DOA) Testing Market Size Market Share by Players
3.1.1 Global At-Home Drug of Abuse (DOA) Testing Revenue by Players (2019-2024)
3.1.2 Global At-Home Drug of Abuse (DOA) Testing Revenue Market Share by Players (2019-2024)
3.2 Global At-Home Drug of Abuse (DOA) Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 At-Home Drug of Abuse (DOA) Testing by Regions
4.1 At-Home Drug of Abuse (DOA) Testing Market Size by Regions (2019-2024)
4.2 Americas At-Home Drug of Abuse (DOA) Testing Market Size Growth (2019-2024)
4.3 APAC At-Home Drug of Abuse (DOA) Testing Market Size Growth (2019-2024)
4.4 Europe At-Home Drug of Abuse (DOA) Testing Market Size Growth (2019-2024)
4.5 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size Growth (2019-2024)
5 Americas
5.1 Americas At-Home Drug of Abuse (DOA) Testing Market Size by Country (2019-2024)
5.2 Americas At-Home Drug of Abuse (DOA) Testing Market Size by Type (2019-2024)
5.3 Americas At-Home Drug of Abuse (DOA) Testing Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC At-Home Drug of Abuse (DOA) Testing Market Size by Region (2019-2024)
6.2 APAC At-Home Drug of Abuse (DOA) Testing Market Size by Type (2019-2024)
6.3 APAC At-Home Drug of Abuse (DOA) Testing Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe At-Home Drug of Abuse (DOA) Testing by Country (2019-2024)
7.2 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Type (2019-2024)
7.3 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa At-Home Drug of Abuse (DOA) Testing by Region (2019-2024)
8.2 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Type (2019-2024)
8.3 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global At-Home Drug of Abuse (DOA) Testing Market Forecast
10.1 Global At-Home Drug of Abuse (DOA) Testing Forecast by Regions (2025-2030)
10.1.1 Global At-Home Drug of Abuse (DOA) Testing Forecast by Regions (2025-2030)
10.1.2 Americas At-Home Drug of Abuse (DOA) Testing Forecast
10.1.3 APAC At-Home Drug of Abuse (DOA) Testing Forecast
10.1.4 Europe At-Home Drug of Abuse (DOA) Testing Forecast
10.1.5 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Forecast
10.2 Americas At-Home Drug of Abuse (DOA) Testing Forecast by Country (2025-2030)
10.2.1 United States At-Home Drug of Abuse (DOA) Testing Market Forecast
10.2.2 Canada At-Home Drug of Abuse (DOA) Testing Market Forecast
10.2.3 Mexico At-Home Drug of Abuse (DOA) Testing Market Forecast
10.2.4 Brazil At-Home Drug of Abuse (DOA) Testing Market Forecast
10.3 APAC At-Home Drug of Abuse (DOA) Testing Forecast by Region (2025-2030)
10.3.1 China At-Home Drug of Abuse (DOA) Testing Market Forecast
10.3.2 Japan At-Home Drug of Abuse (DOA) Testing Market Forecast
10.3.3 Korea At-Home Drug of Abuse (DOA) Testing Market Forecast
10.3.4 Southeast Asia At-Home Drug of Abuse (DOA) Testing Market Forecast
10.3.5 India At-Home Drug of Abuse (DOA) Testing Market Forecast
10.3.6 Australia At-Home Drug of Abuse (DOA) Testing Market Forecast
10.4 Europe At-Home Drug of Abuse (DOA) Testing Forecast by Country (2025-2030)
10.4.1 Germany At-Home Drug of Abuse (DOA) Testing Market Forecast
10.4.2 France At-Home Drug of Abuse (DOA) Testing Market Forecast
10.4.3 UK At-Home Drug of Abuse (DOA) Testing Market Forecast
10.4.4 Italy At-Home Drug of Abuse (DOA) Testing Market Forecast
10.4.5 Russia At-Home Drug of Abuse (DOA) Testing Market Forecast
10.5 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Forecast by Region (2025-2030)
10.5.1 Egypt At-Home Drug of Abuse (DOA) Testing Market Forecast
10.5.2 South Africa At-Home Drug of Abuse (DOA) Testing Market Forecast
10.5.3 Israel At-Home Drug of Abuse (DOA) Testing Market Forecast
10.5.4 Turkey At-Home Drug of Abuse (DOA) Testing Market Forecast
10.5.5 GCC Countries At-Home Drug of Abuse (DOA) Testing Market Forecast
10.6 Global At-Home Drug of Abuse (DOA) Testing Forecast by Type (2025-2030)
10.7 Global At-Home Drug of Abuse (DOA) Testing Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 UCP Biosciences
11.1.1 UCP Biosciences Company Information
11.1.2 UCP Biosciences At-Home Drug of Abuse (DOA) Testing Product Offered
11.1.3 UCP Biosciences At-Home Drug of Abuse (DOA) Testing Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 UCP Biosciences Main Business Overview
11.1.5 UCP Biosciences Latest Developments
11.2 Orient New Life Medical
11.2.1 Orient New Life Medical Company Information
11.2.2 Orient New Life Medical At-Home Drug of Abuse (DOA) Testing Product Offered
11.2.3 Orient New Life Medical At-Home Drug of Abuse (DOA) Testing Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Orient New Life Medical Main Business Overview
11.2.5 Orient New Life Medical Latest Developments
11.3 Express Diagnostics Int鈥檒
11.3.1 Express Diagnostics Int鈥檒 Company Information
11.3.2 Express Diagnostics Int鈥檒 At-Home Drug of Abuse (DOA) Testing Product Offered
11.3.3 Express Diagnostics Int鈥檒 At-Home Drug of Abuse (DOA) Testing Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Express Diagnostics Int鈥檒 Main Business Overview
11.3.5 Express Diagnostics Int鈥檒 Latest Developments
11.4 Assure Tech (Hangzhou)
11.4.1 Assure Tech (Hangzhou) Company Information
11.4.2 Assure Tech (Hangzhou) At-Home Drug of Abuse (DOA) Testing Product Offered
11.4.3 Assure Tech (Hangzhou) At-Home Drug of Abuse (DOA) Testing Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Assure Tech (Hangzhou) Main Business Overview
11.4.5 Assure Tech (Hangzhou) Latest Developments
11.5 Psychemedics Corporation
11.5.1 Psychemedics Corporation Company Information
11.5.2 Psychemedics Corporation At-Home Drug of Abuse (DOA) Testing Product Offered
11.5.3 Psychemedics Corporation At-Home Drug of Abuse (DOA) Testing Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Psychemedics Corporation Main Business Overview
11.5.5 Psychemedics Corporation Latest Developments
11.6 Confirm BioSciences
11.6.1 Confirm BioSciences Company Information
11.6.2 Confirm BioSciences At-Home Drug of Abuse (DOA) Testing Product Offered
11.6.3 Confirm BioSciences At-Home Drug of Abuse (DOA) Testing Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Confirm BioSciences Main Business Overview
11.6.5 Confirm BioSciences Latest Developments
11.7 Phamatech
11.7.1 Phamatech Company Information
11.7.2 Phamatech At-Home Drug of Abuse (DOA) Testing Product Offered
11.7.3 Phamatech At-Home Drug of Abuse (DOA) Testing Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Phamatech Main Business Overview
11.7.5 Phamatech Latest Developments
11.8 Home Health (U.K.) Ltd.
11.8.1 Home Health (U.K.) Ltd. Company Information
11.8.2 Home Health (U.K.) Ltd. At-Home Drug of Abuse (DOA) Testing Product Offered
11.8.3 Home Health (U.K.) Ltd. At-Home Drug of Abuse (DOA) Testing Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Home Health (U.K.) Ltd. Main Business Overview
11.8.5 Home Health (U.K.) Ltd. Latest Developments
11.9 Quest Products
11.9.1 Quest Products Company Information
11.9.2 Quest Products At-Home Drug of Abuse (DOA) Testing Product Offered
11.9.3 Quest Products At-Home Drug of Abuse (DOA) Testing Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Quest Products Main Business Overview
11.9.5 Quest Products Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂